May 11, 2022 / 09:40PM GMT
Unidentified Analyst -
(technical difficulty)
life science tools and diagnostics team working with Derik De Bruin. And joining us for our next slot is Chuck Kummeth, Chief Executive Officer of Bio-Techne. Format's going to be a fire side chat. Feel free to fire off any questions if you want to jump in.
Questions and Answers:
Unidentified Analyst -But just to get the ball rolling, Chuck, since BofA doesn't cover you, maybe you can give us a little bit of introduction, the portfolio, your offerings, how you fit into the life science tools ecosystem?
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Well, we've kind of become a proteomics kind of world lately. I mean a decade ago, it was all about NGS, and all of a sudden lo and behold this proteomics is cool again, a little help in the pandemic but it doesn't hurt. But we're situated position, we think perfectly because of that, we've been around 46 years, and we're the world leader in proteins for research, which is the most fundamental tool
Trustpilot
